4//SEC Filing
Stellar Biotechnologies, Inc. 4
Accession 0001144204-15-072638
$EDSACIK 0001540159operating
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 5:25 PM ET
Size
5.4 KB
Accession
0001144204-15-072638
Insider Transaction Report
Form 4
NIFFENEGGER KATHI
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2015-12-22+10,000→ 10,000 totalExercise: $7.24Exp: 2022-12-18→ Common Shares (10,000 underlying)
Footnotes (1)
- [F1]Option grant under the 2013 Fixed Share Option Plan (the "Plan"), which shall vest as to one-third immediately, as to one-third on December 22, 2016 and as to the remaining one-third on June 22, 2017.
Documents
Issuer
Stellar Biotechnologies, Inc.
CIK 0001540159
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001540159
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 5:25 PM ET
- Size
- 5.4 KB